 Company Also Announces Participation in the BTIG Biotechnology Conference and the Stifel Biotech Summer Summit SEATTLE , Aug. 1, 2022 PRNewswire -- CTI BioPharma Corp. CTI BioPharma NASDAQ: CTIC today announced that management plans to report its second quarter 2022 financial results on Monday, August 8, 2022, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a conference call and webcast to discuss the results and provide a general corporate update at 4:30 p.m. 